ECAT protocol – Adult – 16 years and over

Headache

A4.1 Published: December 2023. Printed on 24 Dec 2024.

QR code link to ECI website

Get the latest version


Any person, 16 years and over, presenting with a headache, excluding suspected stroke (FAST positive).

This protocol is intended to be used by registered and enrolled nurses within their scope of practice and as outlined in The Use of Emergency Care Assessment and Treatment Protocols (PD2024_011). Sections marked triangle or diamond indicate the need for additional prerequisite education prior to use. Check the medication table for dose adjustments and links to relevant reference texts.

If either of the following clinical signs are identified, escalate immediately as per local CERS protocol for advice regarding management. Do not give medication under this protocol. Rapidly complete assessment.

  • Thunderclap headache (“worst ever” headache, severe pain, maximal pain within 1–2 minutes of onset)
  • Headache associated with focal deficit, confusion, personality change, seizure, neck pain or fever

History prompts, signs and symptoms

These are not exhaustive lists. Maintain an open mind and be aware of cognitive bias.

History prompts

  • Presenting complaint
  • Onset of symptoms
  • Pain assessment – PQRST
  • Pre-hospital treatment
  • Past admissions
  • Past medical and surgical history, including headaches or migraines – is this similar or different to usual?
  • Previous neurosurgery, VP shunt or recent trauma
  • Current medications, including anticoagulant therapy
  • Known allergies
  • Vaccination status

Signs and symptoms

  • Aura
  • Photosensitivity
  • Focal deficit
  • Nausea
  • Vomiting

Red flags

Recognise: identify indicators of actual or potential clinical severity and risk of deterioration.

Respond: carefully consider alternative ECAT protocol. Escalate as per clinical reasoning and local CERS protocol, and continue treatment.

Historical

  • Frequent use, 8–10 times, of triptan medications over the past month
  • History of cancer or neoplasm
  • Previous neurosurgery or VP shunts
  • History of trauma
  • Potential poisoning
  • Anticoagulant therapy
  • Non-prescription drug or alcohol use
  • Immunocompromised
  • Over 50 years
  • Pregnancy
  • Post-partum

Clinical

  • Altered level of consciousness
  • Delirium or confusion
  • Different to normal headache pattern or symptoms
  • Severe neck stiffness with reduced mobility
  • Sudden onset
  • Non-blanching petechial rash
  • Diplopia
  • Fever

Remember adult at risk: patient or carer concern, frailty, multiple comorbidities or unplanned return.

Clinical assessment and specified intervention (A to G)

If the patient has any Yellow or Red Zone observations or additional criteria (as per the relevant NSW Standard Emergency Observation Chart), refer and escalate as per local CERS protocol and continue treatment.

Position

AssessmentIntervention

General appearance/first impressions

Position of comfort

Airway

AssessmentIntervention

Patency of airway

Maintain airway patency

Consider airway opening manoeuvres and positioning

Breathing

AssessmentIntervention

Respiratory rate and effort

Consider auscultation of chest (breath sounds)

Oxygen saturations (SpO2)

Assist ventilation, as clinically indicated

Consider oxygen if dyspnoeic, titrate oxygen to maintain SpO2 over 93%

Patients at risk of hypercapnia, maintain SpO2 at 88–92%

Circulation

AssessmentIntervention

Perfusion (capillary refill, skin warmth and colour)

Pulse

Blood pressure

Cardiac rhythm

Assess circulation

Attach cardiac monitor and complete 12 lead ECG if BP/HR are within the Yellow or Red Zones, or where clinically relevant, e.g. irregular pulse, palpitations, syncope, shock, respiratory compromise, cardiac history or clinical concern

IVC and/or pathology

Insert IV cannula, if trained and clinically indicated

If unable to obtain IV access, consider intraosseous, if trained

See pathology section

Signs of shock:

tachycardia and CRT 3 seconds and over

and/or abnormal skin perfusion

and/or hypotension

Headache with signs of shock and/or SBP less than 90 mmHg should be considered sepsis until proven otherwise. Switch to sepsis (suspected) protocol

Disability

AssessmentIntervention

GCS, pupillary response and limb strength

Obtain baseline and repeat assessment as clinically indicated

Pain

Assess pain. If indicated, give early analgesia as per analgesia section then resume A to G assessment

Exposure

AssessmentIntervention
Temperature

If febrile, escalate care as per local CERS protocol

Consider meningitis or encephalitis (suspected) protocol

Skin inspection, including posterior surfaces

If non-blanching rash is present, consider meningitis or encephalitis (suspected) protocol or sepsis (suspected) protocol

Neck stiffness

Assess for neck stiffness (may indicate meningitis):

  • Place chin to chest (flexion)
  • Look up to the roof (extension)
  • Look left and right (right and left rotation)
  • Ear to shoulder (right and left lateral flexion)

Consider meningitis or encephalitis (suspected) protocol

Fluids

AssessmentIntervention
Hydration status: last ate, drank, bowels opened, passed urine or vomited Commence fluid balance chart, as required
Nausea and/or vomiting If present, see nausea and/or vomiting section

Glucose

AssessmentIntervention

BGL

Measure BGL, if clinically indicated

If less than 4 mmol/L, consider hypoglycaemia protocol

Repeat and document assessment and observations to monitor responses to interventions, identify developing trends and clinical deterioration. Escalate care as required according to the local CERS protocol.

Focused assessment

Complete neurological focused assessment.

Precautions and notes

  • A careful history and physical assessment, including precipitating factors, remain the most important part of identifying serious risk features for patients presenting with headaches.
  • Opioids may alter a neurological assessment.
  • Cluster headaches can have similar symptoms to more serious headaches due to their rapid onset. They can be differentiated by their transient nature, lasting a few hours and are often associated with tearing and rhinorrhoea.
  • Headaches may be caused by medication overuse. Opioid analgesics, triptans, and ergots are frequently associated. Patients using these medications more than 10 days per month may be at risk.

Interventions and diagnostics

Specific treatment

  • Some patients with cluster and migraine headaches can benefit from high-flow oxygen therapy. Start trial at 15 L/min via a non-rebreather, if not contraindicated.
  • Consider comfort measures, such as darkened room.

Analgesia

If pain score 1–6 (mild–moderate), give:

  • paracetamol 1000 mg orally once only
  • and/or ibuprofen 400 mg orally once only.

If severe pain present, give analgesia and escalate as per local CERS protocol.


Nausea and/or vomiting

If nausea and/or vomiting is present, give:

  • metoclopramide 10 mg orally or IV/IM once only (over 20 years only)
  • or ondansetron 4 mg orally or IV/IM. If symptoms persist after 60 minutes, repeat once, maximum dose 8 mg
  • or prochlorperazine 5 mg orally once only or 12.5 mg IV/IM once only

Choice of antiemetic should be determined by cause of symptoms.


Radiology

Radiology will depend on the working diagnosis. It needs to be requested by a medical or nurse practitioner. If there is concern for urgent radiology, escalate as per local CERS protocol.


Pathology

  • FBC, UEC
  • Pregnant: urinalysis, check for proteinuria
  • Temp less than 35°C, or 38.5°C and over: take two sets of blood cultures from two separate sites
  • Potential carboxyhaemoglobin poisoning: ABG (if trained) or VBG to assess for carboxyhaemoglobin (COHb) and lactate
  • Warfarinised: INR

Medications

The shaded sections in this protocol are only to be used by registered nurses who have completed the required education.

Drag the table right to view more columns or turn your phone to landscape

Drug Dose Route Frequency

Ibuprofen H, R

400 mg

Oral

Pain score 1–10

Once only

Metoclopramide R

Over 20 years:
10 mg

Oral/IV/IM

Once only

Ondansetron

4 mg

Maximum dose 8 mg

Oral/IV/IM

Repeat once if required after 60 minutes

Oxygen

2–15 L/min, device dependent

Inhalation

Continuous

Paracetamol H

1000 mg

Oral

Pain score 1–10

Once only

5 mg

Oral

Once only

OR

12.5 mg

IV/IM

Once only

Medications with contraindications or requiring dose adjustment are marked:

  • H for patients with known hepatic impairment
  • R for patients with known renal impairment.

Escalate to medical or nurse practitioner.

References

Hide references

Evidence informed

Information was drawn from evidence-based guidelines and a review of latest available research. For more information, see the development process.

Collaboration

This protocol was developed by the ECAT Working Group, led by the Agency for Clinical Innovation. The group involved expert medical, nursing and allied health representatives from local health districts across NSW. Consensus was reached on all recommendations included within this protocol.

Currency Due for review: Jan 2026. Based on a regular review cycle.
Feedback Email ACI-ECIs@health.nsw.gov.au

Accessed from the Emergency Care Institute website at https://aci.health.nsw.gov.au/ecat/adult/headache

Back to top